Let us Joust again.

My first thoughts to your post(s) regarding discussion of potentialities were mixed.

I have long been concerned that the U.S. is becomming a welfare state. And I have been looking at Agoracom as a microcosm of such a welfare state.

Yet, I have met many of the posters and readers of Agoracom and a number of them have become close friends and I greatly value those relationships.

My late father was an avid reader of Agoracom, though never posting. He was also the first U.S. Citizen to visit NPCT`s facilities in Germany (that was not an officer of the company). I am trying to carry on his tradition of investigative investment on high risk speculations.

I have cut back on both my postings and my taking of phone calls. They were both a negative ROI and a drain on my soul.

I do work with proactive investors of NPCT and we are quite active both in the market and in our research. Some post here, some don`t.

I have a great deal of respect for Rubberworm and the stream of information he provides. Zties is second to none in his research and abilities to convey his research through the written word. Geoff I respect though sometimes I have been inclined to pull his canines without anesthesia and have told him so. You and I have done our own battles of words and with respect I believe.

Finnegan, I miss. I owe him much and have tried to get in contact with him to no avail.

So, though I am concerned that any analysis or discussion of potentialities will fall on greedy but lazy/deaf ears (welfare), it is my respect of those that are willing to work and think for themselves that I will post.

I will work up a post and hit the button sometime this afternoon (my intention). But, I`ll begin with these thoughts:

1) Scimax has been discontinued as of April 2005. All licences have been revoked. Yet, Dr. Neuhaus remains on the board of NPCT as of the last 10K (June 30, 2005). Reports indicate that he is bullish on achieving market penetration for NCS and associated patents.

2) ExypnoTech, gmbH. Their annual revenue June 30, 2005 (fiscal 2005) was $586,480 with expenses of $676,222 as reported in the 10K (up from annual revenue of $42,143 ending June 30, 2004).

Yet in the recent 10Q (1st qtr fiscal 2006), ExypnoTech`s 3 month revenue ending September 30, 2005 was $399,736 with expense of $434,313. Two items of interest present themselves (hold while I run to get my calculator).....

... The first is the increase of revenue. If the revenue remains static for fiscal 2006, ExypnoTech will achieve close to $1.2 million revenue. This is a 204% increase in revenue over fiscal 2005. I do not expect revenue to remain static through fiscal 2006.

The second is expenses. In the first fiscal 2006 quarter, ExypnoTech posted $434,313 expenses. Yet in all of fiscal 2005 they posted expenses of $675,222. In first fiscal 2006 quarter, ExypnoTech expenses were 64% of the entire fiscal 2005 expenses. What would account for this large increase in expense? I have my own conjectures and that is for increased production (equipment purchasing). They have not moved. Rent and labor increases (if any) would not account for such a large increase. So, ExypnoTech is growing.

So, I close this post and will keep my calculator ready for my next post where I will address my thoughts on having a reverse split and my thoughts of potentialities of BioAgra.

Regards,

Kent